Familial paraganglioma syndrome: a rare case of secondary hypertension in young patients
DOI:
https://doi.org/10.24265/horizmed.2024.v24n4.16Keywords:
Paraganglioma , Hypertension , Young AdultAbstract
Paragangliomas are uncommon tumors that originate in the autonomic nervous system and whose clinical manifestations result from excessive catecholamine production. Most of those arising from parasympathetic ganglia are located in the neck and at the base of the skull, along the branches of the glossopharyngeal and vagus nerves. On the other hand, sympathetic paragangliomas occur outside the adrenal, gland along the sympathetic chain. Approximately 75 % of them occur in the abdomen, most of which are functional and present with hypersecretion of catecholamines. These tumors exhibit varying degress of aggressiveness and are characterized by a wide spectrum of hereditary predisposition. In fact, more than one-third exhibit such susceptibility. Five hereditary syndromes have been described, each with different pathogenic variants. Moreover, it is known that there are various genotypic and phenotypic correlations associated with each mutation. We present the case of a 26-year-old female patient, with a five-year history of disease, classified as endocrine hypertension. The patient also had elevated urinary fractionated metanephrine. A contrast-enhanced computed tomography (CT) scan revealed a solid mass in the retroperitoneal space. Additionally, magnetic resonance imaging (MRI) detected bilateral tumors at the cervical level which were not associated with functionality. Surgical intervention was performed on the abdominal mass, and the pathological diagnosis confirmed the presence of a well-defined paraganglioma. Despite the low frequency of these tumors, it is important to take them in account in the differential diagnosis of hypertension, especially in young patients, due to their malignant potential and effects on the cardiovascular system.
Downloads
References
Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens [Internet]. 2020;38(8):1443-56.
Fishbein L, Merrill S, Fraker DL, Cohen DL, Nathanson KL. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing. Ann Surg Oncol [Internet]. 2013; 20(5):1444-50.
Pacak K. New Biology of Pheochromocytoma and Paraganglioma. Endocr Pract [Internet]. 2022;28(12):1253-69.
Martinelli S, Maggi M, Rapizzi E. Pheochromocytoma/paraganglioma preclinical models: which to use and why? Endocr Connect [Internet]. 2020;9(12):R251-R260.
Cornu E, Belmihoub I, Burnichon N, Grataloup C, Zinzindohué F, Baron S, et al. Phaeochromocytoma and paraganglioma. Rev Med Interne [Internet]. 2019;40(11):733-41.
Neumann HPH, Young WF Jr, Eng C. Pheochromocytoma and Paraganglioma. N Engl J Med [Internet]. 2019;381(6):552-65. 7. Van Duinen N, Steenvoorden D, Kema IP, Jansen JC, Vriends AHJT, Bayley JP, et al. Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. J Clin Endocrinol Metab [Internet]. 2010;95(1):209-14.
McNicol AM. Update on tumours of the adrenal cortex, phaeochromocytoma and extra-adrenal Histopathology [Internet]. 2011;58(2):155-68. paraganglioma.
Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas. Endocr Pathol [Internet]. 2022;33(1):90-114.
Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, et al. Personalized Management of Pheochromocytoma and Paraganglioma. Endocr Rev [Internet]. 2022;43(2):199-239.
Yan Q, Bancos I, Gruber LM, Bancos C, McKenzie TJ, BabovicVuksanovic D, et al. When Biochemical Phenotype Predicts Genotype: Pheochromocytoma and Paraganglioma. Am J Med [Internet]. 2018;131(5):506-9.
Ramlawi B, David EA, Kim MP, García-Morales LJ, Blackmon SH, Rice DC, et al. Contemporary surgical management of cardiac paragangliomas. Ann Thorac Surg [Internet]. 2012;93(6):1972-6.
Michałowska I, Ćwikła J, Prejbisz A, Kwiatek P, Szperl M, Michalski W, et al. Mediastinal paragangliomas related to SDHx gene mutations. Kardiochir Torakochirurgia Pol [Internet]. 2016;13(3):276-82.
Korpershoek E, Favier J, Gaal J, Burnichon N, Van Gessel B, Oudjik L, et al. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab [Internet]. 2011;96(9):E1472-6.
Ikram A, Rehman A. Paraganglioma [Internet]. Florida: StatPearls; 2022. Disponible NBK549834/
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Horizonte Médico (Lima)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).